Gut microbiota as a target for prevention and treatment of type 2 diabetes: Mechanisms and dietary natural products

Fan Xia,Lu-Ping Wen,Bing-Chen Ge,Yu-Xin Li,Fang-Ping Li,Ben-Jie Zhou
DOI: https://doi.org/10.4239/wjd.v12.i8.1146
2021-08-15
World Journal of Diabetes
Abstract:Type 2 diabetes mellitus (T2DM) is among the most remarkable public health concerns globally. Accumulating research evidence documents that alteration of gut microbiota has an indispensable role in the onset and progression of obesity and T2DM. A reduced microbial diversity is linked to insulin resistance and energy metabolism, especially for the rise of the <i>Firmicutes</i>/<i>Bacteroidetes</i> ratio. Changes in metabolites followed by the gut dysbacteriosis are linked to the presence of T2DM. Moreover, endotoxin leakage and gut permeability caused by gut dysbacteriosis is more of a trigger for the onset and progression of T2DM. Research documents that natural products are remarkable arsenals of bioactive agents for the discovery of anti-T2DM drugs. Many studies have elucidated that the possible mechanisms of the anti-T2DM effects of natural products are remarkably linked to its regulation on the composition of gut microflora and the successive changes in metabolites directly or indirectly. This review presents a brief overview of the gut microbiota in T2DM and several relevant mechanisms, including short-chain fatty acids, biosynthesis and metabolism of branched-chain fatty acids, trimethylamine N-oxide, bile acid signaling, endotoxin leakage, and gut permeability, and describes how dietary natural products can improve T2DM <i>via</i> the gut microbiota.
endocrinology & metabolism
What problem does this paper attempt to address?